The Antioxidant Study

Phase 3

Completed

• Conditions: The Metabolic Syndrome; Metabolic and Endocrine - Normal metabolism and endocrine development and function

• Registration Number: ACTRN12605000744651
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-11-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Metabolic Syndrome

Exclusion Criteria

Type 2 Diabetes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Markers of Insulin Resistance[Assessed at the conclusion of study at 12 months.];Reversal of the Metabolic Syndrome[Assessed at the conclusion of study at 12 months.]

Secondary Outcome Measures

Name	Time	Method
Inflammatory markers[Measured at 12 months.]